Last reviewed · How we verify

NCT06974682

Effect of Target Temperature Management on Intestinal Flora and Its Metabolites in Patients With Cardiac Arrest

Not yet recruiting Last updated 27 August 2025
What this trial tests

trial in Cardiac Arrest (CA) in 35 participants. Not yet recruiting.

Timeline
1 September 2025
Primary endpoint
1 June 2027
1 June 2027

Quick facts

Lead sponsorCapital Medical University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment35
Start date1 September 2025
Primary completion1 June 2027
Estimated completion1 June 2027
Sites1 location across China

Conditions studied

Sponsor

Capital Medical University

Who can join

Adults 18 to 80, any sex, with Cardiac Arrest (CA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on the self-control design, this study explored the dynamic regulation of target temperature management therapy (TTM) on intestinal flora structure and metabolites of patients after cardiopulmonary resuscitation (CPR). This study is a single-center prospective observational study. Patients with spontaneous circulation recovery (ROSC) after CPR and TTM were included before and after self-hypothermia treatment, and the time series changes of intestinal flora and metabolites at some representative time points before and after treatment were compared. Thirty-five adult patients (age ≥18 years) who met the admission criteria were included. Before TTM treatment (0h after ROSC, baseline), 48 h after TTM warming (T1) and 48 h after rewarming (T2), fecal samples (macro-gene sequencing) and blood samples (metabonomics) were collected to analyze the changes of intestinal flora and metabolites in patients with cardiac arrest, and to screen the differential flora and metabolites regulated by TTM and their dynamic correlation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Arrest (CA)

Currently open trials in the same condition.

Other Capital Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06974682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing